Strategic Partnerships Nostrum Biodiscovery is a Barcelona-based spin-off from renowned research centers and has an ongoing collaboration with Almirall and BSC, indicating openness to co-development and large-scale pharma partnerships for AI-driven protein design and therapeutics.

AI Driven Services The company emphasizes AI-enabled molecular modeling and machine-learning Augmentation for design of therapeutics, proteins modulators, and bio-based chemistry, presenting a sales angle around advanced computational services and customized AI-enabled workflows.

Global Expansion With clients in more than 13 countries and active expansion into Asia and Latin America while strengthening US/Europe presence, there are multiple regional selling opportunities and channel partnerships to pursue.

Boutique Scale Small-to-mid sized team (11-50 employees) and revenue in the low millions indicate nimble, high-touch engagement suitable for bespoke, high-value projects with shorter sales cycles than large CROs.

Technology Stack Fit Proficiency in PyTorch and modern web/AI tooling combined with state-of-the-art molecular modeling positions Nostrum as a premium service provider for pharma/biotech teams seeking advanced computational design, AI-driven analytics, and scalable software-enabled R&D.